Abstract:Interventional cardiologists encounter a wide range of lesions that cannot be angiographically distinguished from fixed atherosclerotic obstructive disease. In this case report, we document vasospasm at multiple sites in the coronary territory in a patient presenting with acute coronary syndrome. A 61-year-old woman was referred to our hospital with typical chest pain lasting approximately 1 h. After performing the left coronary artery angiography, a severe tubular stenosis was detected in circumflex (Cx) arte… Show more
“…Several case reports in the literature address the benefit of the administration of intracoronary nitroglycerine in patients who presented with ACS, and this action deferred them from PCI [ 22 – 25 ]. In a case series study by Vishnevsky et al [ 14 ], intracoronary nitroglycerine administration during angiography prior to a scheduled PCI resulted in the resolution of stenosis in all patients.…”
Background
Despite the recommendation of the current guidelines, intracoronary administration of nitroglycerine during coronary angiography is often neglected. We investigated the effect of intra-coronary nitroglycerin on the relief of coronary artery stenosis in the candidates for percutaneous coronary intervention (PCI).
Methods
We included patients with angina pectoris or myocardial infarction who were candidates for PCI. In the coronary angiography, the culprit vessel involved was evaluated, and bolus nitroglycerin at a dose of 25–200 mcg was injected into the affected coronary artery. A significant change in the percentage of coronary artery stenosis was considered a positive response, and these patients were then compared with patients who did not have a substantial change in the percentage of stenosis at the same time. Univariate analysis and then multivariate logistic regression analysis was performed to determine the predictors of response to intracoronary nitroglycerin.
Results
Among 360 patients, 27 (7.5%) responded to nitroglycerine, and 333 (92.5%) were non-responsive. The mean age of patients was 60.2 ± 11.6 years, ranging from 23 to 93 years, and 265 (73.6%) were men. The study groups were not significantly different in the baseline demographic characteristics. The presence of multivessel disease (Odds ratio (OR) = 16.26, 95% confidence interval (CI):2.07–127.6;
P
= 0.008) and stenosis in the left circumflex artery (OR = 3.62, 95% CI: 1.03–12.70;
P
= 0.044) were the independent predictors for nonresponse to nitroglycerine, leading to PCI.
Conclusion
In some cases, especially those without multivessel diseases, intracoronary nitroglycerine administration can efficiently relieve coronary stenosis and prevent unnecessary PCI.
“…Several case reports in the literature address the benefit of the administration of intracoronary nitroglycerine in patients who presented with ACS, and this action deferred them from PCI [ 22 – 25 ]. In a case series study by Vishnevsky et al [ 14 ], intracoronary nitroglycerine administration during angiography prior to a scheduled PCI resulted in the resolution of stenosis in all patients.…”
Background
Despite the recommendation of the current guidelines, intracoronary administration of nitroglycerine during coronary angiography is often neglected. We investigated the effect of intra-coronary nitroglycerin on the relief of coronary artery stenosis in the candidates for percutaneous coronary intervention (PCI).
Methods
We included patients with angina pectoris or myocardial infarction who were candidates for PCI. In the coronary angiography, the culprit vessel involved was evaluated, and bolus nitroglycerin at a dose of 25–200 mcg was injected into the affected coronary artery. A significant change in the percentage of coronary artery stenosis was considered a positive response, and these patients were then compared with patients who did not have a substantial change in the percentage of stenosis at the same time. Univariate analysis and then multivariate logistic regression analysis was performed to determine the predictors of response to intracoronary nitroglycerin.
Results
Among 360 patients, 27 (7.5%) responded to nitroglycerine, and 333 (92.5%) were non-responsive. The mean age of patients was 60.2 ± 11.6 years, ranging from 23 to 93 years, and 265 (73.6%) were men. The study groups were not significantly different in the baseline demographic characteristics. The presence of multivessel disease (Odds ratio (OR) = 16.26, 95% confidence interval (CI):2.07–127.6;
P
= 0.008) and stenosis in the left circumflex artery (OR = 3.62, 95% CI: 1.03–12.70;
P
= 0.044) were the independent predictors for nonresponse to nitroglycerine, leading to PCI.
Conclusion
In some cases, especially those without multivessel diseases, intracoronary nitroglycerine administration can efficiently relieve coronary stenosis and prevent unnecessary PCI.
“…Esenboga et al reported that in patients presenting with myocardial infarction (MI) catheter-induced multiple nonproximal coronary spasms. 4 Usually, atherosclerotic plaques develop at angulation and bifurcations due to shear stress; hence, ostial LMCA lesions are less frequent than mid and distal LM lesions. 5 If some irregularity is seen in the lesion, then atherosclerotic lesions may be more likely.…”
Vasospasm of coronary artery is a well-known cause for acute coronary syndrome (ACS) but left main coronary artery (LMCA) spasm is very rare. It may be iatrogenic or spontaneous. Here we report a case of a 44-year-old female who presented with chronic stable angina and experienced LMCA vasospasm while undergoing coronary angiography.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.